Back to recall look-up

Recall archive

94,355 stored notices, from Jun 20, 2012 to Sep 23, 2026.

5 recalls · page 1 of 1

Drugs

Reported Mar 21, 2018

Oxytocin USP, powder, 1g-bottle, API American Pharmaceutical Ingredients, NDC 58597-7042-3

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

American Pharmaceutical Ingredients LLC

Matched: Brand · Product · Product detailsStability Data Does Not Support Expiry: Stability data from manufacturer does not support expiration dates listed.

1 more product in this recall

FDA (openFDA drug enforcement)

Drugs

Reported Feb 28, 2018

Amitriptyline HCl USP for prescription compounding , packaged in a) 25 g (NDC 58597-8003-4); b) 100 g (NDC…

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

American Pharmaceutical Ingredients LLC

Matched: Brand · Product detailsCGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure…

65 more products in this recall

FDA (openFDA drug enforcement)

Drugs

Reported Jul 12, 2017

Methocarbamol, USP, packaged in a) 100 g container (NDC: 58597-8023-6, b) 500 g container (NDC: 58597-8023-7), c) 1,000…

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

American Pharmaceutical Ingredients LLC

Matched: Brand · Product detailsCGMP Deviations: Lack of quality assurance at the API manufacturer.

FDA (openFDA drug enforcement)

Drugs

Reported Jul 5, 2017

Doxycycline Hyclate USP, active pharmaceutical ingredient, a) 25 g packaged in a 500 cc container (NDC: 58597-8082-4),…

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

American Pharmaceutical Ingredients LLC

Matched: Brand · Product · Product details · Reason for recallLabeling: Not Elsewhere Classified. Manufacturer and product were discovered to be on FDA Import Alert 66-66 for misbranding of active pharmaceutical

FDA (openFDA drug enforcement)

Drugs

Reported Jun 21, 2017

ESTRONE USP, packaged in a) 1g bottle (NDC: 58597-8049-2), c) 5g bottle (NDC: 58597-8049-3), d) 25g bottle (NDC:…

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

American Pharmaceutical Ingredients LLC

Matched: Brand · Product detailscGMP Deviations; lack of quality assurance.

FDA (openFDA drug enforcement)

RecallNow is not a government agency. Every notice above is published by the FDA, USDA FSIS, or CPSC and links back to its source. Back to the look-up